Forms Processing

PRODUCTS

  • Centralized Product Inspection Monitoring Software

    Document your production and control your product inspection devices with data management software ProdX.

  • Manufacturing Execution System (MES) Software: PAS-X

    PAS-X is the market-leading MES (manufacturing execution system) for the pharma and biotech industries. It is run by more than 50 percent of the world’s top 30 pharmaceutical and biotech companies and in more than 1000 installations around the globe.

  • NuAire In-VitroCell™ ES Model NU-5720 CO2 Incubator

    The In-VitroCell™ ES Model NU-5720 is a direct heat 6.65ft3 (160 L) capacity CO2 Incubator featuring humidity monitoring and control using a sensor and 3-liter reservoir to inject water vapor to meet setpoint. Model NU-5720 provides optimal growth conditions for mammalian cells sensitive to humidity fluctuations.

  • Wireless InSite 3D Wireless Prediction Software

    Wireless InSite is a suite of ray-tracing models and high-fidelity EM solvers for the analysis of site-specific radio wave propagation and wireless communication systems. The RF propagation software provides predictions of EM propagation and communication channel characteristics.

  • BIOSTAT STR® Generation 3 Bioreactor With BIOBRAIN

    BIOSTAT STR® single-use bioreactors and the BIOBRAIN automation platform are engineered to allow you to rapidly adapt your biomanufacturing facility to address changing requirements by offering multiple configurations and convenient software upgrades. The generation 3 system is now available with native DeltaV™ and access to our best in class BioPAT® toolbox.

WHITE PAPERS AND CASE STUDIES

  • Technology Selection For Bioavailability Enhancement

    Due to the growing incidence of low drug solubility in the pharmaceutical discovery and development pipeline, the number of enabling technologies that are employed to improve oral drug absorption and bioavailability (BA) are growing. Rational selection methodologies across this array of technologies can improve chances of clinical success, reduce program complexity, and accelerate development timelines.

  • Recombinant Collagen Made Via Fermentation Can Address Key Unmet Market Needs For Safety, Sustainability And Acceptability

    The supply of collagen from traditional animal-based sources has several risks relating to safety, consistent reproducibility, sustainability and consumer acceptability. The production of recombinant collagen made via fermentation-based processes represents a significant opportunity to address these market needs for collagen that is safe, sustainable, reproducible and acceptable to consumers.

  • Design, Storage, And Handling Offer Greater Support With FieldPoint's Field Service Software

    Prior to Fieldpoint, DSH used a manual work order system, so they had no way to conduct a quick online history search on equipment or previous service work performed by their technicians

  • How To Recognize And Deal With Phishing Scams

    For several decades, email has been the primary form of professional and casual communication on the internet. In April 2019, it was estimated that 293.6 billion emails are sent around the globe each day. Because it is such a widely used form of communication, there are those who seek to take advantage of its scope and exploit it. Statista reports that over 55% of emails sent are considered spam. Although spam inboxes assist in weeding these imposter messages out, there are still many that slip through filters and end up where trustworthy emails are sent. These emails, disguised as legitimate, are actually phishing scams that aim to attack users like you.

  • Sodexo Wields Microsoft Solutions In Global Transformation

    Global facilities management giant, Sodexo, has harnessed Microsoft technologies, including Azure, Dynamics 365, IoT Hub and Power BI, to underpin a major digital and business transformation initiative, beginning in Australia but set to ripple through the international organisation.

  • Guidance For Remote Monitoring For Sponsors And CROs

    Guidance for implementing remote monitoring as a broad policy at the site level. In light of COVID-19, Veeva proposes that sites and sponsors take a risk-based approach to updating policies and study documents to include only critical elements needed in order to implement remote monitoring quickly while not introducing administrative burden on teams.

  • The Hanor Family Of Companies: Companies Running Faster And Leaner With DocStar

    To enhance efficiencies companywide, Hanor went live with the DocStar Enterprise Content Management (ECM) system with advanced workflow, reporting, and intelligent data capture in March 2017. After more than two years of shopping around, the program was selected primarily for its ability to improve productivity through enhanced interdepartmental collaboration, as well as eliminate time-consuming manual processes.

  • Overcoming Bioavailability Challenges In Oral Formulation Development

    With nearly 90% of developmental pipeline drugs consisting of poorly soluble molecules, formulation experts must address this obstacle by applying approaches to improve an API’s pharmacokinetics. 

  • Quality Assurance In Additive Production

    Whether in research or in production, the laser parameters must be checked regularly. For this purpose, Fraunhofer Research Institution for Additive Manufacturing Technologies IAPT generally turns to the Ophir BeamWatch AM, which measures the laser beam without contact, is compact enough to be used inside the production chamber, and delivers measurement results quickly. This case study covers the full story.

  • 8 Challenges Of Sales And Marketing Alignment

    As blatantly obvious as it sounds, Sales and Marketing alignment is beyond critical for any organization. According to the Aberdeen Group, 74% of best-in-class organizations have a strong relationship between Sales and Marketing. So why is such common knowledge often hard to act on – let alone perfect?

  • How Payspan Conquered The Unique Challenges Of NAS Migrations In Healthcare

    Complex unstructured data migration tests healthcare payments company.

  • Optimizing Protocol Design And Enhancing Patient Enrollment

    An emerging biopharmaceutical company was designing a Phase II trial in patients who had Type 2 Diabetes, Stage 3 chronic kidney disease (CKD) and macroalbuminuria. They were uncertain about how to balance the selection of the right patients for their trial endpoints with the ability to achieve rapid subject recruitment. Read how LabCorp de-identified clinical laboratory data helped evaluate the protocol feasibility and the overall design of the study while also making an adjustment in eligibility criteria was forecast to double the eligible patient pool – without impacting study endpoints.

NEWS